| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 150.06% | BTIG | $2 → $10 | Maintains | Buy |
| 05/25/2023 | -56.24% | EF Hutton | → $1.75 | Initiates Coverage On | → Buy |
| 05/18/2023 | -49.99% | BTIG | $3 → $2 | Maintains | Buy |
| 04/24/2023 | -24.98% | BTIG | $3 → $3 | Maintains | Buy |
| 03/10/2023 | -24.98% | BTIG | → $3 | Maintains | Buy |
| 02/06/2023 | 125.06% | Oppenheimer | $12 → $9 | Maintains | Outperform |
| 02/05/2023 | -12.48% | BTIG | $3.5 → $3.5 | Maintains | Buy |
| 01/05/2023 | 0.03% | Scotiabank | → $4 | Initiates Coverage On | → Sector Outperform |
| 12/12/2022 | -12.48% | BTIG | → $3.5 | Assumes | → Buy |
| 07/18/2022 | 200.08% | Oppenheimer | → $12 | Assumes | → Outperform |
| 04/07/2022 | 75.04% | BTIG | $10 → $7 | Maintains | Buy |
| 06/16/2021 | 150.06% | BTIG | → $10 | Initiates Coverage On | → Buy |
| 12/04/2020 | — | Roth Capital | Downgrades | Buy → Neutral | |
| 09/24/2020 | -68.74% | Ladenburg Thalmann | → $1.25 | Initiates Coverage On | → Buy |
| 04/08/2020 | -62.49% | Oppenheimer | → $1.5 | Initiates Coverage On | → Outperform |
What is the target price for Bionano Genomics (BNGO)?
The latest price target for Bionano Genomics (NASDAQ: BNGO) was reported by BTIG on August 10, 2023. The analyst firm set a price target for $10.00 expecting BNGO to rise to within 12 months (a possible 150.06% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bionano Genomics (BNGO)?
The latest analyst rating for Bionano Genomics (NASDAQ: BNGO) was provided by BTIG, and Bionano Genomics maintained their buy rating.
When is the next analyst rating going to be posted or updated for Bionano Genomics (BNGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionano Genomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionano Genomics was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
Is the Analyst Rating Bionano Genomics (BNGO) correct?
While ratings are subjective and will change, the latest Bionano Genomics (BNGO) rating was a maintained with a price target of $2.00 to $10.00. The current price Bionano Genomics (BNGO) is trading at is $4.00, which is within the analyst's predicted range.